Eden Peptides: The GLP-1 Compounds and How They Work

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on GLP-1 therapies, weight management protocols, and the genetic variables that shape every metabolic decision. Browse all Peptides & GLP-1 education

Independent editorial review. PlexusDx has no commercial relationship with Eden or its parent company and earns nothing from this page; no affiliate links appear here.

Full head-to-head: PlexusDx vs Eden →

Eden is frequently described as a “peptide” program, so it helps to be precise about which peptides are actually in play and how they reach the patient. This overview walks through the compounds behind Eden’s GLP-1 offering, how they are delivered, and where a pathway view fits. Fair-balance framing, not a buying recommendation. Updated July 2026.

The peptides behind Eden’s program

The peptides at the center of Eden’s weight-management offering are GLP-1 receptor agonists such as semaglutide and the GIP/GLP-1 dual agonist tirzepatide. Eden operates as telehealth plus a 503A compounding pharmacy: a licensed provider reviews intake and, if eligible, routes a prescription for compounded semaglutide or tirzepatide, or an FDA-approved brand through a retail pharmacy. See Eden’s official website for its current lineup.

How Eden delivers its peptide protocols

Eden dispenses these peptides as injections only, bills strictly month to month with no multi-month plans, and prices by compound rather than dose. Its headline is $99/month for compounded semaglutide and $199/month for compounded tirzepatide as medication only; a required membership ($99/month, $39 the first month) lifts the true recurring total to $198 and $298 all-in, with nothing charged until a provider approves. Eden figures verified at checkout, July 2026.

The science behind GLP-1 and GIP peptides

These peptides work by mimicking incretin hormones: GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) engage the GLP-1 receptor, while tirzepatide adds GIP activity as a dual agonist. The pivotal programs — STEP for semaglutide (The New England Journal of Medicine, 2021), SURMOUNT for tirzepatide (NEJM 2022), and SURMOUNT-OSA (NEJM 2024) — studied distinct populations and endpoints. Outcomes vary individually.

Calling these compounds “peptides” is accurate but broad. They are specifically incretin-mimetic peptides engineered for durability in the body, which is why they are dosed weekly rather than with every meal. That engineering, not a generic peptide category, is what the clinical programs above actually evaluated, and it is the reason formulation and sourcing matter so much.

The PlexusDx peptide protocol range

PlexusDx offers the same two peptide classes through its Weight Management Protocols, but in more formats: Semaglutide Injection at $189/month and Tirzepatide Injection at $289/month, plus Semaglutide Oral at $289/month and Tirzepatide Oral at $349/month — oral routes Eden does not carry — billed month to month with no membership gate.

Mapping your peptide pathways before you start

Every one of these peptides acts on a genetic terrain that varies from person to person. Variants in FTO, the fat-mass and obesity-associated gene, together with GLP1R, MC4R, and TCF7L2, describe the peptide-related biology underneath any protocol. The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights across this landscape. It does not predict how you will respond to any peptide, but it turns a protocol decision into an informed, test-before-you-invest conversation with your provider.

Not affiliated: PlexusDx is not affiliated with Eden and has no commercial relationship with the companies reviewed in this article.

Related reading on PlexusDx: GLP 1 Hormone, What Is GLP 1, GLP 1 What Is, GLP 1 Receptor Agonist.

Disclaimer: This article is educational. PlexusDx is not affiliated with Eden and has no commercial relationship with the companies reviewed. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways — it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

Explore the full peptide range: the Weight Management Protocols, or start upstream with the Precision Peptide Genetic Test.

Frequently Asked Questions

What peptides does Eden offer?

Eden’s weight-management peptides are GLP-1 receptor agonists such as semaglutide and the GIP/GLP-1 dual agonist tirzepatide, dispensed as injections through a compounding or retail pharmacy after provider review. The precise formulations available depend on your prescription; confirm the current lineup on Eden’s own site.

Are Eden’s peptides FDA-approved?

It depends on the pathway. Compounded semaglutide or tirzepatide from a 503A pharmacy is prepared patient-specifically and is not FDA-approved in the way branded products are, while an FDA-approved brand routed through a retail pharmacy is. Ask which applies to your order before starting.

How many peptides does PlexusDx analyze?

The Precision Peptide Genetic Test reads 14 pathways, 49 peptides, 150+ genetic insights, mapping variants such as FTO and GLP1R that shape peptide-related biology. It does not predict response to any specific compound; it provides pathway-level context to discuss with your healthcare provider before a protocol.

Should I test my peptide pathways first?

Testing upstream is optional but informative. Because peptides act on a genetic terrain that differs by individual, mapping your pathways before starting turns a protocol choice into a more informed conversation. It does not replace clinical judgment or predict outcomes, but it adds context most programs skip.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education